Twinning for the Armenian Research Infrastructure on Cancer Research (ARICE) aims to increase the research infrastructure capacities in the field of cancer research in Armenia, through integrating a robust pathology background with state-of-the-art biobanking to a research-ready data structure. This will be achieved by establishing close cooperation with the leading expert-institutions in the field (Medical University Graz, Charles University and IARC) as well as by facilitating spread of the competences at institutional, national and regional level. Cancer research infrastructure has been chosen as the focus because Armenia has a very high incidence and mortality of cancers, as well as a very high prevalence (according to incidence) among rare malignant diseases, while it underperforms in cancer research when compared to the EU average. ARICE will ensure cancer research infrastructure gets appropriate attention in order to support further local research in Armenia and in the wider Caucasus region, including former Soviet Republics. New scientific developments in the field of cancer prevention, in particular in biomarker research and large population-based investigations are in place to facilitate success in research in this field. The ARICE project is going to be an important step for reaching the set goals both efficiently and effectively. The competences acquired in this field during the project realization will be easily transferable to other fields of research related to medicine, biology and medical ethics, health-economics and biostatistics. Involvement of researchers from multiple specialities (physicians of different specialities, biologists, data management specialists) hosted by the Yerevan State Medical University (YSMU) will ensure this smooth transfer of expertise.

The NextGEM vision is to assure safety for EU citizens when employing existing and future EMF based telecommunication technologies. This will be accomplished by generating relevant knowledge that ascertains appropriate prevention and control/actuation actions of EMF exposure in residential, public, and occupational settings. Fulfilling the vision will provide a healthy living and working environment, under safe EMF exposure conditions, that can be trusted by people and be in line with the regulations and laws of the public authorities. For that, NextGEM will provide a framework for the generation of health-relevant scientific knowledge and data on new scenarios of exposure to EMF in multiple frequency bands, and develop and validate tools for evidence based risk assessment. NextGEM will also create the NextGEM Innovation and Knowledge Hub (NIKH) for EMF and Health offering a standardised way for European regulatory authorities and the scientific community to store and assess project outcomes, and provide access to FAIR data.. NextGEM is part of the European cluster on EMFs and health.

HPV-FASTER-Implement aims to improve cervical cancer (CC) prevention. Although human papillomavirus (HPV) vaccination and CC screening programmes have significantly reduced mortality, they have reached a plateau because they remain largely inaccessible and underused by vulnerable populations, creating inequalities in the European healthcare system. This adds to the difficulties already faced by vulnerable populations in their efforts to maintain their mental and physical health. HPV-FASTER-Implement will create a Europe-wide knowledge framework on vulnerabilities and the health challenges they pose, as well as the tools to monitor their evolution. HPV-FASTER-Implement will work with stakeholder representatives, primarily from vulnerable populations, to identify context-specific strategies to deliver combined HPV vaccines and HPV-based CC screening to eligible vulnerable populations, thereby reducing the burden of CC in Europe. HPV-FASTER-Implement will develop health education interventions, communication activities and other services to meet the need of vulnerable population with high risk of CC and inadequate access to health services. Through stakeholder engagement, health literacy promotion, mathematical modelling, implementation research, and vulnerability mapping, we will collect, analyse and share knowledge on gaps and opportunities to improve CC prevention in Europe, and progress FASTER towards CC elimination. We will work to ensure that the data we produce are translated into policy recommendations aimed at strengthening national prevention programmes with interventions tailored to vulnerable populations. In this way, we can leverage limited resources to rapidly reduce CC mortality. We aim to reduce health inequalities by offering an innovative prevention intervention to women at risk, with the hope that 50% of those offered the intervention will take it. HPV-FASTER-Implement will make the necessary improvements to European CC prevention policies.